Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Lymphadenopathy, Lymphoedema, Myalgia, Nausea
Clinical narrative: Lymphedema in left arm and chestwall ( I am a breast cancer patient; chestwall tightness; shortness of breath; Extreme pain in total body/Very bad pain on left side were mastectomy is, with tightness/ horrible pain throughout entire body; low temperature of 96.5; clammy; pale; Costipation; Numbness in fingers; low resting heart rate of 43-46; extreme pain in total body including bones; extreme pain in total body including abdomen; extreme pain in total body including throat; weakness; extreme pain in total body including joints; swollen lymph nodes under arms, groin, chestwall, throat area and ears; extreme pain in total body including muscles; chills; headache; extreme fatigue; nausea; right back side of head pain; This is a spontaneous report from a contactable other HCP (patient). A 47-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number: 301308A), via an unspecified route of administration on 18Sep2021 at 10:45 (at the age of 47-years-old) in right arm as dose 2, single for covid-19 immunisation at pharmacy or drug store. Medical history included Stage 2B invasive ductal carcinoma left breast, hypertension, anxiety, migraine, lymphedema left side, sensitive gut, constipation, osteopenia, radiation induced fibrosis (left side chest wall), photophobia, PVST, MTBI, RBBB, allergy to Penicillin, molds, grasses, shrubs, bees/wasps, lactose intolerance, and seasonal asthma all from an unknown date and unknown if ongoing. The patient previously took avelox, morphine and demerol and experienced drug hypersensitivity from all. The patient was not diagnosed with covid-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Concomitant medications received within 2 weeks of vaccination included anastrozole (ANASTROZOLE); alprazolam (ALPRAZOLAM); hydrocodone (HYDROCODONE) and lisinopril (LISINOPRIL) all taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: FF2588), via an unspecified route of administration on 28Aug2021 at 12:45 (at the age of 47-years-old) in right arm as dose 1, single for covid-19 immunisation. On 18Sep2021 at 13:00, the patient experienced lymphedema in left arm and chest wall (breast cancer patient), left chest wall tightness, extreme fatigue, extreme pain in total body including abdomen, throat, bones, muscles, joints, shortness of breath, headache, chills, low temperature of 96.5, clammy, pale, weakness, right back side of head pain, swollen lymph nodes under arms, groin, chest wall, throat area and ears. Numbness in fingers, low resting heart rate of 43-46 while awake and in horrible pain throughout entire body, constipation, nausea. Very bad pain on left side were mastectomy is, with tightness. No hospitalisation required. Since the vaccination, the patient was tested for covid-19. On 13Sep2021, the patient underwent lab tests and procedures which included rapid lab swab test: negative (nasal swab); on 16Sep2021, rapid lab test (she works in nursing home, so she got tested twice a week): negative (nasal swab); on 18Sep2021, body temperature: 96.5 (low temperature); low resting heart rate: 43-46. Device date was reported as 20Sep2021. The patient did not receive any treatment. The outcome of all the events at the time of last observation was recovering.  Follow-up attempts are completed. No further information is expected.